Literature DB >> 17073749

The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics.

D N Lavery1, I J McEwan.   

Abstract

The AR (androgen receptor) is a ligand-activated transcription factor and member of the steroid receptor superfamily. The AR responds to the ligands testosterone and dihydrotestosterone and activates multiple downstream genes required in development and reproduction. During the events of transactivation, the AR makes specific protein-protein interactions with several basal transcription factors such as TBP (TATA-box-binding protein) and TFIIF (transcription factor IIF). These interactions occur predominantly within a defined region termed AF1 (activation function-1) located within the highly disordered N-terminal domain of the receptor. Our focus is on the structural aspects of AF1 and how this flexible and disordered domain generates functional interactions with regulators of transcription. Our working hypothesis is that AR-AF1 domain exhibits induced folding when contacted by transcription regulators (such as TFIIF) into a more compact and 'active' conformation, enabling further co-regulator recruitment and ultimately transcription. Structural flexibility and intrinsic disorder of AR-AF1 were studied using predictive algorithms and fluorescence spectroscopy under different experimental conditions and the results revealed this domain retains characteristics indicative of molten-globule or pre-molten-globule-like structures. We hypothesize that this partially folded intermediate state is important for, and enables the AF1 domain to make, multiple protein-protein interactions. The structural aspects of AR-AF1 and interactions with TFIIF are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17073749     DOI: 10.1042/BST0341054

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  12 in total

Review 1.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

2.  Structural diversity and evolution of the N-terminal isoform-specific region of ecdysone receptor-A and -B1 isoforms in insects.

Authors:  Takayuki Watanabe; Hideaki Takeuchi; Takeo Kubo
Journal:  BMC Evol Biol       Date:  2010-02-12       Impact factor: 3.260

3.  General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.

Authors:  Shibing Yu; Yu Jiang; Deborah L Galson; Min Luo; Yumei Lai; Yi Lu; Hong-Jiao Ouyang; Jian Zhang; Guozhi Xiao
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

4.  Effects of different osmolytes on the induced folding of the N-terminal activation domain (AF1) of the glucocorticoid receptor.

Authors:  R Kumar; J M Serrette; S H Khan; A L Miller; E B Thompson
Journal:  Arch Biochem Biophys       Date:  2007-06-29       Impact factor: 4.013

5.  Intrinsic disorder in nuclear hormone receptors.

Authors:  Matthew D Krasowski; Erica J Reschly; Sean Ekins
Journal:  J Proteome Res       Date:  2008-07-24       Impact factor: 4.466

6.  A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.

Authors:  Krista K Hill; Sarah C Roemer; David N M Jones; Mair E A Churchill; Dean P Edwards
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

7.  New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer.

Authors:  Abhijit M Godbole; Vincent C O Njar
Journal:  Prostate Cancer       Date:  2011-10-12

8.  FBI-1 functions as a novel AR co-repressor in prostate cancer cells.

Authors:  Jiajun Cui; Yutao Yang; Chuanfu Zhang; Pinliang Hu; Wei Kan; Xianhong Bai; Xuelin Liu; Hongbin Song
Journal:  Cell Mol Life Sci       Date:  2010-09-02       Impact factor: 9.207

9.  Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancer.

Authors:  Manish Kohli; Rui Qin; Rafael Jimenez; Scott M Dehm
Journal:  Adv Urol       Date:  2012-08-22

10.  The role of androgen receptor mutations in prostate cancer progression.

Authors:  G N Brooke; C L Bevan
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.